Clinical Scorecard: High Incidence of False-Positive Results in Malaria Rapid Diagnostic Tests Among Ugandan Children Under Five
At a Glance
Category
Detail
Condition
Malaria diagnosis using rapid diagnostic tests (mRDTs)
Key Mechanisms
mRDTs detect HRP-2 antigen which can persist post-treatment causing false-positive results
Target Population
Children under 5 years old in Uganda
Care Setting
Point-of-care settings including drug shops, formal health clinics, and community health workers
Key Highlights
False-positive mRDTs (mRDT positive but microscopy negative) prevalence was 10.7% among under-5 children in Uganda.
False-positive results were more common in children with recent fever, recent antimalarial use, and comorbid anemia.
False-positive mRDTs contribute to overestimation of malaria prevalence and may lead to misdiagnosis and unnecessary antimalarial use.
Guideline-Based Recommendations
Diagnosis
Use microscopy as gold standard where feasible, though limited by resource constraints.
Interpret positive mRDT results cautiously in children with recent antimalarial treatment due to antigen persistence.
Consider clinical, environmental, and household factors to better predict false-positive mRDTs.
Management
Avoid unnecessary antimalarial treatment in cases suspected of false-positive mRDTs to prevent drug resistance.
Ensure management of nonmalarial febrile illnesses is not neglected when mRDT is positive but microscopy is negative.
Monitoring & Follow-up
Monitor regional malaria transmission intensity as it correlates with false-positive mRDT prevalence.
Track recent fever, antimalarial and antibiotic use, and anemia status to assess risk of false-positive results.
Risks
False-positive mRDTs may lead to misdiagnosis and inappropriate antimalarial use.
Overuse of antimalarials increases risk of Plasmodium resistance, particularly artemisinin resistance.
Nonmalarial febrile illnesses may be undertreated due to false-positive malaria diagnosis.
Patient & Prescribing Data
Children under 5 years old in Uganda presenting with fever or recent antimalarial use
False-positive mRDTs are common in this group, especially after recent antimalarial treatment, suggesting need for cautious prescribing to avoid unnecessary antimalarial use.
Clinical Best Practices
Use mRDTs as initial screening but confirm with microscopy when possible.
Consider recent clinical history including fever and antimalarial use before interpreting mRDT results.
Incorporate clinical, environmental, and household data to improve prediction of false-positive mRDTs.
Promote stewardship of antimalarial drugs to reduce resistance development.
Maintain vigilance for nonmalarial causes of fever despite positive mRDT results.
